Holders — by stockHoldings — by fund
Exome Asset Management LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0002011932
$153.0M
disclosed book value
55
positions
7.9%
largest position share
Positions, as of 2026-09-30
top 55 of 55 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | GHGUARDANT HEALTH INC | 67,500 | $12.0M | 7.9% |
| 2 | TGTXTG THERAPEUTICS INC | 187,671 | $10.5M | 6.8% |
| 3 | ABVXABIVAX SA | 90,919 | $9.0M | 5.9% |
| 4 | PRAXPRAXIS PRECISION MEDICINES I | 29,681 | $8.6M | 5.6% |
| 5 | COGTCOGENT BIOSCIENCES INC | 210,523 | $6.7M | 4.4% |
| 6 | LLYELI LILLY & CO | 5,492 | $6.4M | 4.2% |
| 7 | NTRANATERA INC | 13,800 | $5.7M | 3.7% |
| 8 | VERAVERA THERAPEUTICS INC | 159,556 | $5.2M | 3.4% |
| 9 | VKTXVIKING THERAPEUTICS INC | 147,497 | $4.8M | 3.1% |
| 10 | IONSIONIS PHARMACEUTICALS INC | 107,034 | $4.8M | 3.1% |
| 11 | ELVNENLIVEN THERAPEUTICS INC | 100,203 | $4.6M | 3% |
| 12 | CAICARIS LIFE SCIENCES INC | 146,093 | $4.5M | 2.9% |
| 13 | NKTRNEKTAR THERAPEUTICS | 73,708 | $4.5M | 2.9% |
| 14 | CYTKCYTOKINETICS INC | 60,056 | $4.0M | 2.6% |
| 15 | VSTMVERASTEM INC | 429,041 | $3.5M | 2.3% |
| 16 | MAZEMAZE THERAPEUTICS INC | 114,692 | $3.1M | 2% |
| 17 | RYTMRHYTHM PHARMACEUTICALS INC | 32,209 | $3.1M | 2% |
| 18 | TXG10X GENOMICS INC | 30,074 | $2.7M | 1.8% |
| 19 | ALKSALKERMES PLC | 61,336 | $2.5M | 1.6% |
| 20 | UTHRUNITED THERAPEUTICS CORP DEL | 4,109 | $2.2M | 1.5% |
| 21 | BSXBOSTON SCIENTIFIC CORP | 48,347 | $2.1M | 1.4% |
| 22 | ARWRARROWHEAD PHARMACEUTICALS IN | 32,214 | $2.1M | 1.4% |
| 23 | UNHUNITEDHEALTH GROUP INC | 5,697 | $2.1M | 1.4% |
| 24 | OCULOCULAR THERAPEUTIX INC | 272,046 | $2.1M | 1.4% |
| 25 | ALMSALUMIS INC | 282,253 | $2.1M | 1.4% |
| 26 | PENPENUMBRA INC | 6,300 | $2.0M | 1.3% |
| 27 | ISRGINTUITIVE SURGICAL INC | 4,908 | $2.0M | 1.3% |
| 28 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 166,493 | $1.9M | 1.3% |
| 29 | CMPSCOMPASS PATHWAYS PLC | 153,087 | $1.9M | 1.2% |
| 30 | CLDXCELLDEX THERAPEUTICS INC NEW | 56,269 | $1.8M | 1.2% |
| 31 | MRKMERCK & CO INC | 12,358 | $1.8M | 1.2% |
| 32 | LQDALIQUIDIA CORPORATION | 59,155 | $1.8M | 1.2% |
| 33 | GKOSGLAUKOS CORP | 10,862 | $1.8M | 1.2% |
| 34 | GLUEMONTE ROSA THERAPEUTICS INC | 137,015 | $1.6M | 1.1% |
| 35 | BBIOBRIDGEBIO PHARMA INC | 21,209 | $1.4M | 0.9% |
| 36 | CLPTCLEARPOINT NEURO INC | 110,174 | $1.3M | 0.9% |
| 37 | CRBPCORBUS PHARMACEUTICALS HLDGS | 190,714 | $1.3M | 0.8% |
| 38 | CTMXCYTOMX THERAPEUTICS INC. | 460,067 | $1.3M | 0.8% |
| 39 | PVLAPALVELLA THERAPEUTICS INC NE | 7,809 | $1.1M | 0.7% |
| 40 | ASNDASCENDIS PHARMA A/S | 4,414 | $1.0M | 0.7% |
| 41 | RAPPRAPPORT THERAPEUTICS INC | 29,381 | $987,202 | 0.6% |
| 42 | BLLNBILLIONTOONE INC | 8,983 | $956,151 | 0.6% |
| 43 | ZBIOZENAS BIOPHARMA INC | 34,341 | $926,177 | 0.6% |
| 44 | REPLREPLIMUNE GROUP INC | 68,488 | $906,781 | 0.6% |
| 45 | EQEQUILLIUM INC | 552,956 | $898,554 | 0.6% |
| 46 | ESTAESTABLISHMENT LABS HLDGS INC | 13,100 | $840,627 | 0.5% |
| 47 | CLYMCLIMB BIO INC | 71,215 | $816,836 | 0.5% |
| 48 | NBPNOVABRIDGE BIOSCIENCES | 576,960 | $787,550 | 0.5% |
| 49 | DRUGBRIGHT MINDS BIOSCIENCES INC | 14,715 | $733,101 | 0.5% |
| 50 | CMPXCOMPASS THERAPEUTICS INC | 511,084 | $531,527 | 0.3% |
| 51 | QTTBQ32 BIO INC | 62,589 | $517,611 | 0.3% |
| 52 | CAPRCAPRICOR THERAPEUTICS INC | 51,531 | $487,999 | 0.3% |
| 53 | QUREUNIQURE NV | 18,300 | $442,128 | 0.3% |
| 54 | ABUSARBUTUS BIOPHARMA CORP | 50,166 | $239,793 | 0.2% |
| 55 | ADAGADAGENE INC | 52,543 | $168,138 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.